ArticleInvestigational new drugs2022

Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non‑small cell lung cancer.

Ari Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.